Skip to content
healthcare.dev

Tavaborole

NDC 21922-020, TAVABOROLE topical solution, 5%, solution, from Encube Ethicals, Inc..

Product NDC
21922-020
Status
Listed
Labeler
Encube Ethicals, Inc.
Dosage form
SOLUTION
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211297
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21922-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAVABOROLE43.5 mg/mL

Pharmacologic classes

Boron Compounds [CS]; Oxaborole Antifungal [EPC]; Protein Synthesis Inhibitors [MoA]

Package NDCNDC-11Package
21922-020-12219220020121 BOTTLE, WITH APPLICATOR in 1 CARTON (21922-020-12) / 10 mL in 1 BOTTLE, WITH APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/050f5d10-5591-426e-9020-6516b3363304
  • NADAC price for package 21922002012

    GET /v1/drugs/nadac/21922002012

Use it

Look up 21922-020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21922-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21922-020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.